Close Menu

NEW YORK – The National Institute of Standards and Technology (NIST) is developing a synthetic SARS-CoV-2 RNA reference material, with the aim of helping companies that are developing molecular diagnostics for the virus to measure the sensitivity of their assays by running tests against known quantities of viral RNA.

The agency is providing the material to labs and diagnostics developers and asking for feedback on how to improve it before disseminating more widely.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.